Several studies show that mice with melanocytes presenting the above-mentioned V600E B-Raf mutation develop benign melanocytic hyperplasia that does not progress to melanoma until a subsequent mutation of PTEN transforms hyperplasia to fully malignant and metastatic melanomas [21]. This evidence concerns the gene PTEN and melanoma.